Literature DB >> 15589024

Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure.

Mark D Sullivan1, Wayne C Levy, Barbara A Crane, Joan E Russo, John A Spertus.   

Abstract

In a prospective cohort study of 142 outpatients with advanced heart failure followed for a mean of 3 years, 29% of subjects with a depression diagnosis at baseline were significantly more likely to experience the combined end point of death or transplantation (hazard ratio 2.54, 95% confidence interval 1.16 to 5.55). After adjustment for a range of sociodemographic and clinical characteristics, patients with depressive disorders were still significantly more likely to reach the combined end point (hazard ratio 2.41, 95% confidence interval 1.24 to 4.68). Depressed patients also had more heart failure related hospitalizations (1.5 +/- 1.8 vs 0.6 +/- 1.4, p = 0.04) and clinic visits (2.4 +/- 1.7 vs 1.7 +/- 1.8, p = 0.04) over the first year of follow-up.

Entities:  

Mesh:

Year:  2004        PMID: 15589024     DOI: 10.1016/j.amjcard.2004.08.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

Review 1.  Effect of depression on prognosis in heart failure.

Authors:  Kenneth E Freedland; Robert M Carney; Michael W Rich
Journal:  Heart Fail Clin       Date:  2011-01       Impact factor: 3.179

2.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

3.  Depression increases the risk of mortality in patients with heart failure: A meta-analysis.

Authors:  Emily C Gathright; Carly M Goldstein; Richard A Josephson; Joel W Hughes
Journal:  J Psychosom Res       Date:  2017-01-24       Impact factor: 3.006

4.  Expert Opinion-Depression in Patients with Heart Failure: Is Enough Being Done?

Authors:  Amam Mbakwem; Francis Aina; Casmir Amadi
Journal:  Card Fail Rev       Date:  2016-11

Review 5.  Palliative care for end-stage heart failure.

Authors:  Sarah J Goodlin
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 6.  Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.

Authors:  James K Rustad; Theodore A Stern; Kathy A Hebert; Dominique L Musselman
Journal:  Prim Care Companion CNS Disord       Date:  2013-08-15

7.  Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.

Authors:  Kenneth C Bilchick; Yongfei Wang; Alan Cheng; Jeptha P Curtis; Kumar Dharmarajan; George J Stukenborg; Ramin Shadman; Inder Anand; Lars H Lund; Ulf Dahlström; Ulrik Sartipy; Aldo Maggioni; Karl Swedberg; Chris O'Conner; Wayne C Levy
Journal:  J Am Coll Cardiol       Date:  2017-05-30       Impact factor: 24.094

8.  Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis.

Authors:  I Sokoreli; J J G de Vries; S C Pauws; E W Steyerberg
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

9.  From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure.

Authors:  Omar F AbouEzzeddine; Benjamin French; Sultan A Mirzoyev; Allan S Jaffe; Wayne C Levy; James C Fang; Nancy K Sweitzer; Thomas P Cappola; Margaret M Redfield
Journal:  J Heart Lung Transplant       Date:  2016-01-15       Impact factor: 10.247

10.  Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart failure.

Authors:  Jia-Rong Wu; Terry A Lennie; Rebecca L Dekker; Martha J Biddle; Debra K Moser
Journal:  J Card Fail       Date:  2013-05       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.